2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC

Eur Heart J. 2016 Jul 14;37(27):2129-2200. doi: 10.1093/eurheartj/ehw128. Epub 2016 May 20.
No abstract available

Keywords: Arrhythmias; Cardiac resynchronization therapy; Co-morbidities; Diagnosis; Ejection fraction; Guidelines; Heart failure; Hospitalization; Mechanical circulatory support; Multidisciplinary management; Natriuretic peptides; Neuro-hormonal antagonists; Pharmacotherapy; Transplantation.

Publication types

  • Practice Guideline

MeSH terms

  • Acute Disease
  • Algorithms
  • Anemia, Iron-Deficiency / complications
  • Angina Pectoris / complications
  • Arthritis / complications
  • Biomarkers / metabolism
  • Cardiac Imaging Techniques / methods
  • Cardiac Resynchronization Therapy / methods
  • Cardiotonic Agents / therapeutic use
  • Central Nervous System Diseases / complications
  • Chronic Disease
  • Coronary Disease / complications
  • Diabetes Complications
  • Echocardiography / methods
  • Electrocardiography / methods
  • Erectile Dysfunction / etiology
  • Evidence-Based Medicine
  • Exercise Therapy / methods
  • Genetic Testing / methods
  • Healthy Lifestyle
  • Heart Failure / diagnosis
  • Heart Failure / etiology
  • Heart Failure / therapy*
  • Heart Transplantation / methods
  • Heart Valve Diseases / complications
  • Humans
  • Hypercalcemia / complications
  • Hyperlipidemias / complications
  • Hypertension / complications
  • Hypokalemia / complications
  • Kidney Diseases / complications
  • Lung Diseases / complications
  • Male
  • Myocardial Revascularization
  • Neoplasms / complications
  • Obesity / complications
  • Physical Examination
  • Prognosis
  • Sleep Wake Disorders / complications
  • Stroke Volume / physiology
  • Terminology as Topic
  • Ventricular Dysfunction / diagnosis

Substances

  • Biomarkers
  • Cardiotonic Agents